IMATINIB MESILATE

( DrugBank: Imatinib / KEGG DRUG: Imatinib )

3 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	2
86	肺動脈性肺高血圧症	4

告示番号	疾患名（ページ内リンク）	臨床試験数
88	慢性血栓塞栓性肺高血圧症	1

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2018-000620-34-DE (EUCTR)	06/05/2020	08/11/2019	Imatinib treatment for Multiple Sclerosis (MS) Relapses	Imatinib for Multiple Sclerosis (MS) Relapses - a Phase II, Randomised Study - Imatinib MS	Patients with clinically definite Multiple Sclerosis (MS) according to the McDonald Criteria, or pos ...	INN or Proposed INN: IMATINIB MESILATE INN or Proposed INN: Methylprednisolone Other descriptive name: ...	Department of Clinical Neuroscience, Karolinska Institutet	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 2	Germany;Sweden
2	EUCTR2018-000620-34-SE (EUCTR)	24/04/2018	14/03/2018	Imatinib treatment for Multiple Sclerosis (MS) Relapses	Imatinib for Multiple Sclerosis (MS) Relapses - a Phase II, Randomised Study - Imatinib MS	Patients with clinically definite Multiple Sclerosis (MS) according to the McDonald Criteria, or pos ...	INN or Proposed INN: IMATINIB MESILATE Trade Name: Solu-Medrol Product Name: Solu-Medrol INN or Propose ...	Department of Clinical Neuroscience, Karolinska Institutet	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 2	Sweden

First Previous1Next Last

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 4 of 4 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-001157-48-GB (EUCTR)	28/07/2020	09/07/2020	PIPAH study: Using imatinib (drug) in Pulmonary Arterial Hypertension	Identifying a safe and tolerated dose of Imatinibforpatients with Pulmonary Arterial Hypertension (P ...	Pulmonary Arterial Hypertension (Idiopathic, heritable, or assosicated with anorexigens) MedDRA vers ...	Trade Name: Imatinib mesilate Product Name: Imatinib mesilate INN or Proposed INN: Imatinib mesilate	Imperial College London	NULL	Authorised-recruitment may be ongoing or finished	Female: yes Male: yes	43	Phase 2	United Kingdom
2	EUCTR2013-001100-10-ES (EUCTR)	12/11/2013	12/11/2013	This study is to allow continued access to QTI571 for patients whoreceived QTI571 for pulmonary arte ...	An open-label, multi-center protocol to provide QTI571 to PAH patients who participated in one of th ...	Pulmonary Arterial Hypertension MedDRA version: 16.1;Level: PT;Classification code 10064911;Term: Pu ...	Trade Name: GLIVEC 100 mg comprimidos recubiertos con película Product Name: Imatinib mesilate Product ...	Novartis Farmacéutica, S.A.	NULL	Not Recruiting	Female: yes Male: yes	81		United States;Spain;Australia;Switzerland
3	EUCTR2010-021960-14-DE (EUCTR)	08/04/2011	03/03/2011	An open-label extension study to CQTI571A2102 to evaluate the long-term safety, tolerability and eff ...	An open-label extension study to CQTI571A2102 to evaluate the long-term safety, tolerability and eff ...	Pulmonary arterial hypertension (PAH) MedDRA version: 14.1;Level: PT;Classification code 10064911;Te ...	Trade Name: Glivec® Product Code: QTI571 INN or Proposed INN: IMATINIB MESILATE Trade Name: Glivec® Prod ...	Novartis Pharma AG	NULL	Not Recruiting	Female: yes Male: yes	20		Germany;Italy
4	EUCTR2009-012057-38-DE (EUCTR)	13/08/2009	10/06/2009	A 24-week randomized placebo-controlled, double-blind multi-center clinical trial evaluating the eff ...	A 24-week randomized placebo-controlled, double-blind multi-center clinical trial evaluating the eff ...	Pulmonary arterial hypertension (PAH) patients who have a PVR =800 dynes.sec.cm-5 despite treatment ...	Trade Name: Glivec® 100 mg Filmtabletten Product Code: QTI571 INN or Proposed INN: Imatinib mesilate	Novartis Pharma Services AG	NULL	Not Recruiting	Female: yes Male: yes	200		United Kingdom;Germany;Netherlands;Belgium;France;Spain;Italy;Austria;Sweden

First Previous1Next Last

88. 慢性血栓塞栓性肺高血圧症

臨床試験数 : 157 / 薬物数 : 107 - (DrugBank : 22) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 54

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-001157-48-GB (EUCTR)	28/07/2020	09/07/2020	PIPAH study: Using imatinib (drug) in Pulmonary Arterial Hypertension	Identifying a safe and tolerated dose of Imatinibforpatients with Pulmonary Arterial Hypertension (P ...	Pulmonary Arterial Hypertension (Idiopathic, heritable, or assosicated with anorexigens) MedDRA vers ...	Trade Name: Imatinib mesilate Product Name: Imatinib mesilate INN or Proposed INN: Imatinib mesilate	Imperial College London	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	43	Phase 2	United Kingdom

First Previous1Next Last